Helus Pharma (HELP) Stock Analysis
NASDAQHealthcareMedical - Pharmaceuticals
Track HELP in your portfolio for free · Portfolio tracker
What Helus Pharma does
Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.
Key metrics
ETFs linked to HELP
Broad-market and Healthcare sector ETFs an investor holding Helus Pharma is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how HELP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze HELP in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Helus Pharma?
- Helus Pharma trades under the ticker HELP on NASDAQ.
- Which exchange is HELP listed on?
- HELP is listed on NASDAQ.
- What sector does Helus Pharma operate in?
- Helus Pharma is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
- How can PortView help analyze HELP in a portfolio?
- PortView shows HELP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.